Biotech Stocks

biotech stocks Clovis Oncology (CLVS) Knocked Out By FDA Inquiry
Source: ©
Biotechnology has been one of the fastest advancing industries in the past decade. With new medicine always being synthesized and new ways to fertilize crops, the sector is diverse and prosperous, especially as corporations look for new findings or better efficiency. Subsequently, the biotech stocks are booming and should continue to rise in the future.
Some of the best biotech stocks to buy in 2014 include Amgen (NYSE:AMGN) and Gilead Sciences (NYSE:GILD) although many smaller biotech corporations are on the rise and worth a consideration. Biotech stocks can cure your ailing portfolio and lead you down the road to recovery.

Biotechnology Sector Quote (CIX: MSECTOR5151)

Recent Articles

Clovis Oncology (CLVS) Knocked Out By FDA Inquiry

Clovis Oncology Inc suffered a massive setback to its lung cancer treatment program, erasing years of gains made by CLVS stock. More 

Watch Powerhouse Biotech’s Mesoblast IPO Closely

Investors, get ready: Australian stem cell biotech, Mesoblast, has filed with the SEC to raise up to $70 million in its IPO. It's a steal. More 

Here’s Why You Should Buy More CELG Shares After Earnings Dip

Third quarter show that CELG continues to grow its business, it continues to make product people like and that Revlimid hasn't peaked yet. More 

Eight Ways to Leverage the Small-Cap Biotech Bull Market

SeeThruEquity's Ajay Tandon and Jay Albany are riding the biotech bull by harnessing the huge upside potential of these micro-cap companies More 

Gilead Sciences, Inc. – GILD Stock Catches the Bears Off Guard Again

Biotechnology stocks as a group are not yet out of the woods, but single-name stocks like GILD stock look promising right now. More 

Trade of the Day: Biotech Double – Mannkind (MNKD) and PDL BioPharma (PDLI)

Biotech stocks got hit hard in recent weeks as concerns about prescription drug prices mounted. More 

IPO Buzz: Dimension Therapeutics Gears Up For a Debut

After a sudden and steep drop, biopharma stocks are seeing green shoots again. Keep an eye on Dimension Therapeutics's IPO. More 

4 Biotech Stocks Now at Bargain Prices

Biotech stocks have been battered of late, but not all these biotechnology names deserved their drubbing. Here are four to pick up while the dust is still settling. More 

10 Biotech Stocks to Watch in Q4

Fans of biotech stocks have a lot to look forward to in the fourth quarter, with trial updates and a few potential drug approvals in the works. More 

Politics, Price Gouging and Healthcare Potential (REGN, IBB, BIIB)

We saw a wave of selling in biotech stocks during the week, but here's why I'm still bullish on healthcare, and biotech in particular. More